Physician profile

Saeed Payvar

Cardiovascular Disease · Mount Airy, NC

NPI 1134339104

$40,479.94

in general payments reported to CMS, 2019-2025

38 companies · $16K in 2025

The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$24,085.49
Food and Beverage$5,318.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $21,800.69 2021-2025 In.Pact Admiral, Symplicity G3, Abre
Bard Peripheral Vascular, INC. $3,546.59 2019-2023 Rotarexs 6 F X 135 Cm
Cms Imaging, INC. $2,973.63 2025
Abbott Laboratories $2,626.89 2019-2025 Optis, Xience Skypoint, Diamondback Peripheral
Cardiovascular Systems INC. $1,908.22 2019-2022
Ekos Corporation $1,376.37 2019
Boston Scientific Corporation $1,060.11 2021-2025 Watchman Access System, Varithena Administration Pack, Express Ld Iliac / Biliary
Cook Incorporated $931.18 2021
Philips North America LLC $641.62 2022-2025 Igt Devices Systems Undivided, Labosys, Encore
Shockwave Medical, INC $591.43 2019-2022
Cook Medical LLC $461.12 2019-2024 Zilver Ptx
Merit Medical Systems INC $323.92 2021
Inari Medical, INC. $310.66 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Amgen INC. $269.83 2022-2025 Repatha, Repatha
Baxter Healthcare $246.55 2022-2023 Hillrom - Cardiac Ambulatory Monitor
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Impulse Dynamics (USA) INC. $238.18 2023 Optimizer
E.R. Squibb & Sons, L.L.C. $160.89 2022-2025 Camzyos, Eliquis
Medtronic Vascular, INC. $158.72 2020
Heartflow, INC. $149.05 2022-2025 Ffrct
Pfizer INC. $82.62 2022-2025
Novartis Pharmaceuticals Corporation $74.68 2021-2024
Esperion Therapeutics, INC. $66.21 2022-2023 Nexletol
Cvrx, INC. $64.12 2023-2024 Barostim Neo System
Merck Sharp & Dohme LLC $50.48 2022
Surmodics, INC. $50.15 2022
Novo Nordisk INC $48.92 2024 Rybelsus, Ozempic
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $40.63 2022-2023 Lifevest
Janssen Pharmaceuticals, INC $30.78 2021-2022
Atricure, INC. $29.75 2023-2024
Getinge USA Sales, LLC $25.20 2019-2020
Kiniksa Pharmaceuticals, LTD. $21.32 2023 Arcalyst
Irhythm Technologies, INC. $20.21 2019
Bardy Diagnostics, INC. $19.00 2022
Tactile Systems Technology INC $18.60 2025 Nimbl, Flexitouch Plus
Kerecis Limited $18.46 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen
Organogenesis INC. $16.59 2022
Angiodynamics, INC. $15.37 2024 Alphavac
Ossur Americas, INC. $11.20 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Saeed Payvar

$40,479.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/277934/saeed-payvar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.